Page 41 - 《中国药房》2022年23期
P. 41

结果显示,清热活血汤可呈剂量依赖地改善 MIRI 模型                             缺血再灌注损伤的影响及机制[J].中国循证心血管医学
          大鼠血清中氧化应激相关指标水平。                                        杂志,2016,8(7):800-803.
              综上所述,清热活血汤可改善 MIRI 模型大鼠心脏                      [16]  HEUSCH  G.  Myocardial  ischaemia-reperfusion  injury  and
          组织损伤,其药效成分包括黄芩苷、隐丹参酮、异阿魏                                cardioprotection in perspective[J]. Nat Rev Cardiol,2020,
          酸、原儿茶醛等,其作用机制可能与改善心肌能量代谢、                               17(12):773-789.
                                                             [17]  韩晶岩.心气虚血瘀的科学内涵和芪参益气滴丸补气活
          下调氧化应激水平、抑制炎症浸润有关。
                                                                  血的作用机理[J]. 世界科学技术-中医药现代化,2019,
          参考文献
                                                                  21(2):139-147.
          [ 1 ]  马文君,马涵萍,王运红,等.《2021年中国心血管病医疗                [18]  KANDZARI  D  E,TCHENG  J  E.  Double  negatives[J].
              质量报告》概要[J].中国循环杂志,2021,36(11):1041-1064.            Am Heart J,2003,145(1):9-11.
          [ 2 ]  JIN Z,ZHANG W B,LUO Y,et al. Protective effect of
                                                             [19]  AN J,VARADARAJAN S G,CAMARA A,et al. Blocking
              Qingre  Huoxue  decoction  against  myocardial  infarction   Na(+)/H(+) exchange reduces[Na(+)](i) and[Ca(2+)]
              via  PI3K/Akt  autophagy  pathway  based  on  UPLC-MS,  (i)  load  after  ischemia  and  improves  function  in  intact
              network  pharmacology,and  in  vivo  evidence[J].  Pharm
                                                                  hearts[J]. Am J Physiol Heart Circ Physiol,2001,281(6):
              Biol,2021,59(1):1607-1618.                          H2398-H2409.
          [ 3 ]  左强,褚庆民,金政,等.清热活血方治疗急性ST段抬高                  [20]  JI H Y,XIAO F,LI S B,et al. GRP78 effectively protect
              型心肌梗死的前瞻性、多中心队列研究[J]. 中医杂志,                         hypoxia/reperfusion-induced  myocardial  apoptosis  via
              2021,62(3):229-234.
                                                                  promotion of the Nrf2/HO-1 signaling pathway[J]. J Cell
          [ 4 ]  纪树亮,李睿,孙治中,等 . 基于网络药理学及分子对接                      Physiol,2021,236(2):1228-1236.
              探讨清热活血方对心肌缺血再灌注损伤的保护作用机制                       [21]  YU L M,LI S,TANG X L,et al. Diallyl trisulfide amelio‐
              [J].中西医结合心脑血管病杂志,2022,20(19):3531-3537.             rates myocardial ischemia-reperfusion injury by reducing
          [ 5 ]  黄继汉,黄晓晖,陈志扬,等 . 药理试验中动物间和动物                      oxidative  stress  and  endoplasmic  Reticulum  stress-
              与人体间的等效剂量换算[J]. 中国临床药理学与治疗                          mediated apoptosis in type 1 diabetic rats:role of SIRT1
              学,2004,9(9):1069-1072.                              activation[J]. Apoptosis,2017,22(7):942-954.
          [ 6 ]  李睿,王祎昕,纪树亮,等 . 大鼠心肌缺血再灌注损伤模                 [22]  SONG  S  L,TAN  J,MIAO  YY,et  al.  Crosstalk  of
              型改良置管法[J]. 中国病理生理杂志,2022,38(10):                    autophagy and apoptosis:involvement of the dual role of
              1913-1920.                                          autophagy  under  ER  stress[J].  J  Cell  Physiol,2017,232
          [ 7 ]  WHEELOCK Å M,WHEELOCK C E. Trials and tribula‐  (11):2977-2984.
              tions of ’omics data analysis:assessing quality of SIMCA-  [23]  刘雨露,朱子贵,张建新,等 . α-玉柏碱减轻大鼠心肌缺
              based  multivariate  models  using  examples  from  pulmo‐  血再灌注损伤[J].药物分析杂志,2022,42(2):287-293.
              nary medicine[J]. Mol Biosyst,2013,9(11):2589-2596.  [24]  韦艺丹,许美娟,季晖.花生四烯酸的ω-羟化代谢途径与
          [ 8 ]  NIUX  M,MIS,JIN  Q  X,et  al.  Characterizationand  di-   心脑血管疾病[J]. 中国临床药理学与治疗学,2016,21
              scrimination  of  two  varieties  of  eggplants  using  multi-  (7):826-833.
              element  and  metabolomics  profiles  coupled  with  chemo‐  [25]  KRAEMER M P,MAO G G,HAMMILL C,et al. Effects
              metrics analysis[J]. Food Res Int,2022,162:111976.  of  diet  and  hyperlipidemia  on  levels  and  distribution  of
          [ 9 ]  HAUSENLOY D J,YELLON D M. Ischaemic conditioning   circulating lysophosphatidic acid[J]. J Lipid Res,2019,60
              and reperfusion injury [J]. Nat Rev Cardiol,2016,13(4):  (11):1818-1828.
              193-209.                                       [26]  WU X G,LI Y,ZHANG S C,et al. Ferroptosis as a novel
          [10]  刘萍,唐代,王旭,等 . 黄芩苷对心肌缺血再灌注损伤的                       therapeutic target for cardiovascular disease[J]. Theranostics,
              保护作用机制[J].中医药学报,2021,49(2):16-21.                   2021,11(7):3052-3059.
          [11]  黄浪,徐策,许光宇.黄芩苷对冠心病大鼠缺血再灌注损                    [27]  谢锋,段广靖,屈新亮,等 . TRP 通道对心肌缺血再灌注
              伤的治疗作用及机制[J].山东医药,2018,58(37):40-44.                损伤保护作用研究进展[J]. 海南医学院学报,2022,28
          [12]  XU  M,LI  X  Y,SONG  L  C.  Baicalin  regulates  macro‐  (19):1511-1515,1520.
              phages  polarization  and  alleviates  myocardial  ischaemia/  [28]  XIE M,CHO G W,KONG Y L,et al. Activation of auto-
              reperfusion  injury  via  inhibiting  JAK/STAT  pathway[J].   phagic  flux  blunts  cardiac  ischemia/reperfusion  injury[J].
              Pharm Biol,2020,58(1):655-663.                      Circ Res,2021,129(3):435-450.
          [13]  WEI G,GUAN Y,YIN Y,et al. Anti-inflammatory effect   [29]  CHENG YY,CHENG L K,GAO X,et al. Covalent modi‐
              of protocatechuic aldehyde on myocardial ischemia/reper‐  fication of Keap1 at Cys77 and Cys434 by pubescenoside
              fusion injury in vivo and in vitro[J]. Inflammation,2013,  a  suppresses  oxidative  stress-induced  NLRP3  inflamma‐
              36(3):592-602.                                      some activation in myocardial ischemia-reperfusion injury
          [14]  许佳慧.隐丹参酮与丹参酚酸类化合物的心肌保护作用                          [J]. Theranostics,2021,11(2):861-877.
              及对eNOS/GRK2的调节作用[D].郑州:郑州大学,2019.                             (收稿日期:2022-05-04  修回日期:2022-10-16)
          [15]  郝霁萍,高宇勤,贺少辉,等 . 肉桂酸预处理对大鼠心肌                                                       (编辑:唐晓莲)



          中国药房  2022年第33卷第23期                                              China Pharmacy  2022 Vol. 33  No. 23    · 2851 ·
   36   37   38   39   40   41   42   43   44   45   46